is fda stopping semaglutide Hims & Hers stock falls 25% as curtails compounded GLP-1s Last week @fda sends out

What to do if something goes wrong Even with perfect planning, things go wrong

Observational research presented in March 2026 at the American Academy of Orthopaedic Surgeons annual meeting found that GLP-1 drugs may slightly increase the risk of developing osteoporosis and gout, a kind of inflammatory arthritis caused by a buildup of uric acid

The result is better absorption and none of the bloating or water retention common with powder

Our experienced medical team will provide a complimentary medical consultation to assess your needs and help determine which therapy options may be appropriate for your individual goals